If a Stock Market Crash Is Coming, History Says These 3 ETFs Are the Smartest Buys

You don’t have to look hard to find signs that the stock market’s run is in a precarious position. One example: Warren Buffett’s favorite market valuation metric is well above the level at which he has previously warned that investors are “playing with fire.”

It’s never a good idea to panic if a storm is potentially on the horizon. Instead, prudent investors take wide precautionary steps to be prepared.

Looking to the past to see which investments have held up better than others can be especially instructive. If a stock market crash is coming, history shows that these three exchange-traded funds (ETFs) rank among the smartest choices.

Image source: Getty Images.

1. Schwab U.S. Dividend Equity ETF

The Schwab U.S. Dividend Equity ETF (SCHD +0.73%) has become a favorite among income investors for good reason. It pays a solid 3.3% dividend yield and has paid regular quarterly distributions since its inception 15 years ago.

However, this ETF isn’t only a good pick for income investors if a stock market crash is around the corner. The quality of the 102 stocks in the Schwab U.S. Dividend Equity ETF’s portfolio makes the fund one of the better defensive investment alternatives around.

SCHD Schwab U.S. Dividend Equity ETF

$34.35+$0.25 (+0.73%)

NYSEMKT · As of 4:00 PM ET 10/16/26

The ETF attempts to track the performance of the Dow Jones U.S. Dividend 100 Index. This index focuses on U.S. stocks that consistently pay dividends with attractive yields and are fundamentally strong compared to their peers.

Roughly 41% of the Schwab U.S. Dividend Equity ETF’s holdings are consumer staples and healthcare stocks. Both sectors tend to outperform most others during steep market downturns.

2. Health Care Select Sector SPDR Fund

Speaking of healthcare, the State Street Health Care Select Sector SPDR Fund (XLV -0.27%) offers one of the easiest ways to invest in the sector. This ETF holds 60 of the largest healthcare stocks, with top holdings including Eli Lilly (LLY +0.43%), Johnson & Johnson (JNJ +0.90%), AbbVie (ABBV +0.71%), Merck (MRK +0.52%), and UnitedHealth Group (UNH -1.29%).

The State Street Health Care Select Sector SPDR Fund has handily outperformed the S&P 500 (^GSPC -1.09%) over the last 12 months. That isn’t surprising considering the rising uncertainty that investors are facing.

XLV Select Sector SPDR Trust – State Street Health Care Select Sector SPDR ETF

$176.71-$0.48 (-0.27%)

NYSEMKT · As of 4:00 PM ET 10/16/26

People don’t stop taking medications or forego seeking medical treatment for serious issues because the stock market falls. As a result, healthcare companies’ businesses tend to be highly resilient.

To be sure, the State Street Health Care Select SPDR Fund isn’t immune to market downturns. For example, the ETF declined when the dot-com bubble burst in 2000 and in the financial crisis of 2008. However, its pullback was much less severe, and it recovered much more quickly than the overall market in both periods.

3. SPDR Bloomberg 1-3 Month T-Bill ETF

What’s Warren Buffett’s favorite investment when turbulence is likely? Short-term Treasury bonds. Roughly $325 billion of Berkshire Hathaway‘s (BRKA +1.08%) (BRKB +1.21%) cash was parked in short-term Treasuries as of the end of the second quarter. The State Street SPDR Bloomberg 1-3 Month T-Bill ETF (BIL +0.03%) provides a straightforward way for investors who aren’t billionaires to follow Buffett’s lead.

As its name indicates, this ETF offers exposure to U.S. Treasury bills with remaining maturities between one and three months. It attempts to track the performance of the Bloomberg 1-3 Month U.S. Treasury Bill Index.

BIL SPDR Series Trust – State Street SPDR Bloomberg 1-3 Month T-Bill ETF

$91.57+$0.03 (+0.03%)

NYSEMKT · As of 4:00 PM ET 10/16/26

The State Street SPDR Bloomberg 1-3 Month T-Bill ETF currently pays a distribution yield above 4%. And because the Treasuries it owns are so short-duration, it isn’t experiencing the volatility that many bond funds are these days as interest rates rise.

This fund won’t deliver tremendous returns if the stock market crashes. What it will do, though, is protect investors’ capital and generate reliable income while they wait for great opportunities to buy stocks at a discount. This approach has worked quite well for Buffett through the years.

Source link

Visited 1 times, 1 visit(s) today

Related Article

President Donald Trump Claims Gasoline Prices Will “Drop Like a Rock” When the Iran War Ends, but He’s Completely Missed the Bigger Picture

The stock market has endured some of its wildest volatility under President Donald Trump, including the five-week COVID-19 crash in February-March 2020 and the week-long tariff tantrum in April 2025. But more importantly, the timeless Dow Jones Industrial Average (DJINDICES:^DJI), benchmark S&P 500 (SNPINDEX:^GSPC), and tech-powered Nasdaq Composite (NASDAQINDEX:^IXIC) have soared with Trump in the

Should You Sell Your NuScale Power Stock Now?

Image from Pixabay Investors holding NuScale Power (SMR) stock have faced a punishing year. While the broader S&P 500 returned 17.9%, the shares lost 86.6%. That decline is firmly embedded in the current valuation, regardless of whether you choose to sell or hold. Anyone maintaining a position now owns an enterprise with minimal revenue, waiting

Africa’s richest man plans to open his Ethiopian fertiliser business to investors through at least 10% stock-market listing

The fertiliser proposal concerns a manufacturing venture in Gode, southeastern Ethiopia, designed to produce three million tonnes of urea annually. A local listing would create a potential route for investors to participate in that Ethiopian business. However, no share price, offer timetable or final transaction structure has been disclosed. It is also

Yellow Cake (AIM:YCA) Stock May Look Reasonable Given Its Earnings Exposure

Yellow Cake has delivered a 34.1% gain over the past 5 years, yet the recent softer share price leaves a clear question for you as an investor. Is the current valuation supported by the company’s earnings power or has the market moved ahead of what its profit stream can justify? A 34.1% return over 5

Stocktwits Defense Watch: RTX Continues Deal Momentum, Ondas-Palantir Launch AI Firm As AeroVironment Strike Four International Deals

RTX received $729 million in counter-drone orders from the U.S., Qatar and Jordan. AeroVironment expanded its international drone partnerships in Australia, Taiwan, Spain and Israel Ondas and Palantir to launch an AI defense firm called Regna AI. Even as bank earnings and a tech selloff dominated market headlines this week, defense stocks were in the

Can Trade Desk Stock Bounce Off Its Old Support Again?

Image from Pixabay Investors holding Trade Desk (TTD) have seen the stock lose 74.1% of its value over the past year, compared with a 17.9% return for the S&P 500. The immediate question is how much further shares might drop. One certainty is the current level: at $13.13 on October 15, the stock sits above

3 Canadian Growth Stocks To Watch With Up To 47% Earnings Growth

Energy costs are climbing again as crude oil trades above US$100, and that pressure hits weaker balance sheets first. Canadian companies that are already investing for growth, and where executives hold meaningful stakes, can sometimes handle higher input costs and financing hurdles more confidently. This article looks at three such fast growing, high insider ownership

TomTom (ENXTAM:TOM2) Q3 Results Leave Stock Waiting For Revenue Recovery

TomTom just reported Q3 2026 and the reaction in the stock tells you almost as much as the numbers. The share price closed at €3.8 on 16 October after a flat week and a weak 3‑month stretch, yet the latest report shows €129.0m in quarterly revenue with a 90% gross margin and positive earnings per

1 Obvious Metric That Makes Nvidia a Top Stock to Buy Now

Nvidia (NASDAQ: NVDA) may be the world’s largest company by market cap, but that doesn’t mean that its sales and earnings can’t get bigger. However, if you look at how the stock market is valuing the company, then it’s pretty obvious that the market thinks they won’t. This gap is a major investment opportunity, because

Ladder Capital Corp Q3 2026 Earnings Call Summary

Ladder Capital Corp Q3 2026 Earnings Call Summary – Moby Strategic Performance and Market Positioning Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we’ll show you why it’s our #1 pick. Tap here. Performance was driven by a $31 million gain from the

Prediction: Micron Could Turn $10,000 Into a Fortune by 2030

Micron (NASDAQ: MU) has been a great stock to own in 2026, but I’m betting that it goes even higher by 2030. In fact, it could transform a $10,000 investment made today into a $42,000 position by then — and that’s on the conservative side of my estimated range. That may seem unrealistic, but the

AbbVie or Altria: The One Dividend Stock I’d Hold for the Next 10 Years

AbbVie or Altria: The One Dividend Stock I’d Hold for the Next 10 Years ©89Stocker, towfiqu barbhuiya via Canva Key Takeaways AbbVie lowered its 2026 adjusted EPS guidance to $13.76 to $13.96 on Oct. 5, reflecting $1.25 billion of acquired IPR&D and milestone expense. Altria yields 6.2% against AbbVie’s 2.6%, while AbbVie raised its dividend

Palantir’s record breakout unravels as software stocks shed $260 billion

Palantir (PLTR) was breaking records earlier this week. Now its breakout has reversed, with the stock heading toward correction territory. Shares fell roughly 7% Friday, erasing about $34 billion in market value. The closing number to watch is $188.15. Below that, Palantir would finish more than 10% beneath its Oct. 9 record close, confirming a

Apple Is Up Nearly 12X in 10 Years. Can It Repeat That Run?

Quick Read AAPL turned $10,000 into $127,753 over the last decade, but its $4.96T market cap limits the next 5-year base case to roughly $16,271. iPhone 17 revenue surged 22% to $54B and Services hit $30.7B, powering a record $109B June quarter for Apple. Valuation at 39x earnings, shrinking gross margins, and iPhone 18 Pro

CoreWeave’s rebound is getting tested — here are the levels bulls need to hold

CoreWeave (CRWV) sprang a bear trap Thursday. Now another sell-off is testing whether the bulls can hold their ground. The AI cloud provider’s shares are falling Friday after staging a dramatic reversal the previous session. Shares briefly broke below their summer floor near $60 on Thursday, sank to $59.51, then climbed to $69.76 — a

Moderna stock sinks as Wall Street turns cautious following blistering rally

What happened: Moderna (MRNA) stock tanked 9% on Friday. What’s behind the move: The biotech giant sank as investors took profits and Wall Street grew cautious on the stock’s blistering rally of more than 600% year to date. Goldman Sachs (GS) raised its target on the stock to $137 from $120 on Thursday while maintaining a Neutral

3 Reasons to Buy Silicon Motion Technology Before the End of 2026

It’s no secret that stocks connected to the AI industry have been some of the market’s top performers over the past year, but there are still a few that remain relatively under the radar. Silicon Motion Technology (NASDAQ: SIMO) is one of them. It produces NAND flash controllers, which are vital for AI infrastructure. That’s

0
Would love your thoughts, please comment.x
()
x